LYG:NYSELloyds Banking Group Plc Analysis
Data as of 2026-04-16 - not real-time
$5.61
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Lloyds Banking Group (LYG) is trading at $5.61, comfortably above its 20‑day ($5.21), 50‑day ($5.43) and 200‑day ($4.91) simple moving averages, indicating a short‑term price bias to the upside. The RSI of 61.9 and a bullish MACD histogram reinforce momentum, while the stock remains within a neutral trend envelope between a support of $4.81 and resistance of $5.70. Valuation metrics are attractive – a trailing P/E of 15.2 sits below the industry average of 17.6 and a forward P/E of 10.5 suggests earnings growth ahead. The dividend yield of 3.56% with a payout ratio under 50% adds income appeal, and analyst consensus has recently upgraded to Buy with an average price target of $6.42, implying roughly 14% upside versus the model’s 5.2% upside estimate. Short interest has risen sharply but remains modest at 0.17% of float, meaning less than a day’s trading volume would cover shorts, limiting downside pressure.
The balance sheet shows abundant cash ($171 bn) offset by high debt ($148 bn), yet the debt‑to‑equity ratio is reported as zero, reflecting strong capital adequacy. Operating cash flow is negative, a caution flag, but the firm’s dividend sustainability appears intact given the cash cushion and modest payout. Volatility is elevated at 37.7% over the past 30 days, though beta near 1 indicates market‑aligned risk. Liquidity is slightly constrained as volume trends downward, but market cap remains robust at $82 bn.
Overall, LYG presents an undervalued, income‑focused play with modest upside potential in the near term, balanced by sector‑specific regulatory and geographic exposures that warrant a measured stance for longer horizons.
The balance sheet shows abundant cash ($171 bn) offset by high debt ($148 bn), yet the debt‑to‑equity ratio is reported as zero, reflecting strong capital adequacy. Operating cash flow is negative, a caution flag, but the firm’s dividend sustainability appears intact given the cash cushion and modest payout. Volatility is elevated at 37.7% over the past 30 days, though beta near 1 indicates market‑aligned risk. Liquidity is slightly constrained as volume trends downward, but market cap remains robust at $82 bn.
Overall, LYG presents an undervalued, income‑focused play with modest upside potential in the near term, balanced by sector‑specific regulatory and geographic exposures that warrant a measured stance for longer horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above all major SMAs and bullish MACD signal
- Recent analyst upgrade to Buy with 14% upside target
- Strong dividend yield and low short‑interest coverage
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Undervalued valuation relative to peers (P/E below industry)
- Sustainable dividend providing income buffer
- Moderate volatility and sector‑specific regulatory environment
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Stable cash generation capacity despite negative operating cash flow
- Exposure to UK economic cycles and regulatory changes
- High debt levels offset by large cash reserves and solid capital ratios
Key Metrics & Analysis
Financial Health
Revenue Growth14.40%
Profit Margin25.01%
P/E Ratio15.2
ROE10.15%
ROA0.51%
P/B Ratio6.0
Op. Cash Flow$-7781000192
Industry P/E17.6
Technical Analysis
TrendNeutral
RSI61.9
Support$4.81
Resistance$5.70
MA 20$5.21
MA 50$5.43
MA 200$4.91
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98
Valuation
Target Price$5.90
Upside/Downside5.23%
GradeUndervalued
TypeBlend
Dividend Yield3.56%
Risk Assessment
Beta0.97
Volatility37.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.